Boston Scientific is trading 4.03% up now at $49.66, as healthcare gains 1.31% during the session—the clearest explanation for today’s move.
- Rebounding after closing at $47.74 on August 5.
- July 29 earnings beat estimates, but reduced 2026 guidance and analyst estimate cuts remain overhangs rather than fresh catalysts.
- Broader indexes are mixed.